Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery

Clinical Trial ID NCT02097732

PubWeight™ 10.27‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02097732

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prospects of immune checkpoint modulators in the treatment of glioblastoma. Nat Rev Neurol 2015 1.50
2 Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology 2015 1.06
3 Combinations of immunotherapy and radiation in cancer therapy. Front Oncol 2014 1.01
4 In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment. Vaccine 2015 0.92
5 Immunotherapy for cancer in the central nervous system: Current and future directions. Oncoimmunology 2015 0.88
6 Systemic Immunotherapy for the Treatment of Brain Metastases. Front Oncol 2016 0.82
7 Current clinical trials testing the combination of immunotherapy with radiotherapy. J Immunother Cancer 2016 0.81
8 Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies. Front Oncol 2016 0.78
9 Clinical trials in melanoma patients with brain metastases. Pigment Cell Melanoma Res 2015 0.78
10 Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy. Neuro Oncol 2015 0.75
11 Melanoma Brain Metastasis: Mechanisms, Models, and Medicine. Int J Mol Sci 2016 0.75
12 Embracing rejection: Immunologic trends in brain metastasis. Oncoimmunology 2016 0.75
Next 100